サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1588738

ラクトフェリンの市場規模、シェア、動向分析レポート：機能別、用途別、地域別、セグメント予測、2025年～2030年

Lactoferrin Market Size, Share & Trends Analysis Report By Function (Iron Absorption, Intestinal Flora Protection), By Application (Personal Care Products, Infant Formula), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 140 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
ラクトフェリンの市場規模、シェア、動向分析レポート：機能別、用途別、地域別、セグメント予測、2025年～2030年
出版日: 2024年10月30日
発行: Grand View Research
ページ情報: 英文 140 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ラクトフェリン市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のラクトフェリン市場規模は2030年までに4億8,670万米ドルに達すると推定され、2025年から2030年までのCAGRは8.6%で成長する見込みです。

乳児用食品、食品サプリメント、栄養食品、アルコール飲料、スポーツ栄養、パーソナルケア、化粧品など、様々な製品へのラクトフェリンの配合が増加しており、強い健康上の利点から、予測期間中にラクトフェリン市場を強化するはずです。

ラクトフェリンは、免疫系を刺激し、老化による細胞の損傷を防ぎ、腸管内の有益な細菌の培養を促進し、鉄代謝の調整因子としてウイルス、細菌、真菌を制御します。ラクトフェリンは、細胞内レベルでウイルスの複製を阻害することにより、C型肝炎感染の治療に有効であることが判明しています。従って、栄養補助食品、医薬品、パーソナルケア産業におけるラクトフェリンの強い応用可能性は、予測期間中の需要を促進すると予想されます。

ラクトフェリンの濃度が最も高いのはヒトの初乳で、次いでヒトの母乳、ウシの母乳の順となっています。ラクトフェリンはまた、鼻、目、腸、呼吸器官を含む人体分泌物にも容易に含まれます。ラクトフェリンは、特定の友好的な菌株の結合体として使用することができ、一緒に摂取することで、体の免疫機能を高め、有害な微生物の白血球に警告を発し、腸内細菌のコロニーを安定させることが証明されています。商業的には、ラクトフェリンはこれを達成するためにプロバイオティクスと統合されるのが一般的です。

アジア太平洋のラクトフェリン市場は、2024年に30.70％の最大の収益シェアを占めました。ラクトフェリン市場は、主要な市場プレーヤーが東南アジアの未開拓の経済圏でのプレゼンスを拡大する戦略を採用し続けているため、需要の力強い高まりを目にすると予測されています。中国、日本、オーストラリアを含む国々は、ラクトフェリンの健康上の利点に関する高い認知度を経験しており、予測期間中に地域の成長を強化すると予想されます。

ラクトフェリン市場レポートハイライト

  • 鉄吸収セグメントは2024年に39.3%の最大シェアを占めました。これは主に鉄欠乏症と貧血などの関連疾患の有病率の増加によるもので、世界人口のかなりの部分に影響を及ぼしています。
  • 乳児用調製粉乳セグメントは、乳児のためのラクトフェリンの健康上の利点の意識の高まりによって、2024年に世界のラクトフェリン市場を独占しました。ラクトフェリンは母乳に含まれる重要な成分であり、免疫力を高め、鉄分の吸収を促進することで知られています。
  • 北米は、健康とウェルネスに関する消費者の意識の高まりと機能性食品への需要の高まりが相まって、2024年の世界のラクトフェリン市場で23.3％の売上シェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ラクトフェリン市場の変数、動向、範囲

  • 世界のラクトフェリン市場の見通し
  • 業界バリューチェーン分析
  • 機能概要
  • 平均価格動向分析
  • 需給ギャップ分析、2024年
  • 規制の枠組み
    • ポリシーとインセンティブプラン
    • 標準とコンプライアンス
    • 規制影響分析
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
    • 業界の課題
  • ポーターのファイブフォース分析
    • サプライヤーの力
    • 買い手の力
    • 代替の脅威
    • 新規参入の脅威
    • 競争企業間の敵対関係
  • PESTEL分析
    • 政治情勢
    • 経済情勢
    • 社会情勢
    • 技術的情勢
    • 環境情勢
    • 法的な情勢

第4章 ラクトフェリン市場：機能展望の推定と予測

  • ラクトフェリン市場：機能変動分析、2024年および2030年
    • 鉄の吸収
    • 抗炎症
    • 腸内フローラの保護
    • 抗菌
    • 免疫細胞刺激
    • 抗酸化物質

第5章 ラクトフェリン市場：用途の展望の推定と予測

  • ラクトフェリン市場：用途変動分析、2024年および2030年
    • 食品
    • 乳児用調製粉乳
    • スポーツ＆機能性食品
    • 医薬品
    • パーソナルケア製品
    • その他

第6章 ラクトフェリン市場の地域別展望の推定と予測

  • 地域スナップショット
  • ラクトフェリン市場：地域変動分析、2024年および2030年
  • 北米
    • 市場推計・予測、2018年-2030年
    • 機能別、2018年-2030年
    • 用途別、2018年-2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 市場推計・予測、2018年-2030年
    • 機能別、2018年-2030年
    • 用途別、2018年-2030年
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
  • アジア太平洋
    • 市場推計・予測、2018年-2030年
    • 機能別、2018年-2030年
    • 用途別、2018年-2030年
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリアとニュージーランド
  • ラテンアメリカ
    • 市場推計・予測、2018年-2030年
    • 機能別、2018年-2030年
    • 用途別、2018年-2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 市場推計・予測、2018年-2030年
    • 機能別、2018年-2030年
    • 用途別、2018年-2030年
    • アラブ首長国連邦

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • ベンダー情勢
    • 企業分類
    • 主要販売代理店およびチャネルパートナーのリスト
    • 潜在顧客/エンドユーザーのリスト
  • 競争のダイナミクス
    • 競合ベンチマーキング
    • 戦略マッピング
    • ヒートマップ分析
  • 企業プロファイル/上場企業
    • Hilmar Cheese Company
    • Pharming Group NV
    • FrieslandCamina
    • Synlait Milk Ltd.
    • Ingredia SA
    • MP Biomedicals
    • Tatura Milk Industries Ltd.
    • Glanbia plc
    • APS BioGroup
    • ProHealth
    • Fonterra Cooperative Group Ltd.
    • Farbest Brands
    • InVitria
    • Milei GmbH
    • Ferrin-tech LLC
図表

List of Tables

  • Table 1. List of abbreviations
  • Table 2. Lactoferrin market estimates and forecasts, by Function, 2018 - 2030 (USD Million)
  • Table 3. Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 4. Lactoferrin market estimates and forecasts, by region, 2018 - 2030 (USD Million)
  • Table 5. North America Lactoferrin market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 6. North America Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 7. North America Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 8. U.S. Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 9. U.S. Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 10. Canada Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 11. Canada Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 12. Mexico Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 13. Mexico Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 14. Europe Lactoferrin market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 15. Europe Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 16. Europe Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 17. Germany Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 18. Germany Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 19. UK Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 20. UK Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 21. Italy Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 22. Italy Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 23. France Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 24. France Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 25. Spain Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 26. Spain Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 27. Asia Pacific Lactoferrin market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 28. Asia Pacific Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 29. Asia Pacific Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 30. China Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 31. China Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 32. Japan Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 33. Japan Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 34. India Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 35. India Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 36. South Korea Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 37. South Korea Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 38. Australia & New Zealand Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 39. Australia & New Zealand Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 40. Latin America Lactoferrin market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 41. Latin America Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 42. Latin America Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 43. Brazil Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 44. Brazil Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 45. Argentina Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 46. Argentina Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 47. Middle East & Africa Lactoferrin market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 48. Middle East & Africa Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 49. Middle East & Africa Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 50. UAE Lactoferrin market estimates and forecasts, by function, 2018 - 2030 (USD Million)
  • Table 51. UAE Lactoferrin market estimates and forecasts, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig 1. Market segmentation
  • Fig 2. Information procurement
  • Fig 3. Data analysis models
  • Fig 4. Market formulation and validation
  • Fig 5. Market snapshot
  • Fig 6. Segmental outlook- Function, and application
  • Fig 7. Competitive outlook
  • Fig 8. Value chain analysis
  • Fig 9. Market dynamics
  • Fig 10. Porter's analysis
  • Fig 11. PESTEL analysis
  • Fig 12. Lactoferrin market, by function: Key takeaways
  • Fig 13. Lactoferrin market, by function: Market share, 2024 & 2030
  • Fig 14. Iron absorption market, 2018 - 2030 (USD Million)
  • Fig 15. Antiinflammatory market, 2018 - 2030 (USD Million)
  • Fig 16. Intestinal flora protection market, 2018 - 2030 (USD Million)
  • Fig 17. Antibacterial market, 2018 - 2030 (USD Million)
  • Fig 18. Immune cell stimulation market, 2018 - 2030 (USD Million)
  • Fig 19. Antioxidant market, 2018 - 2030 (USD Million)
  • Fig 20. Lactoferrin market, by application: Key takeaways
  • Fig 21. Lactoferrin market, by application: Market share, 2024 & 2030
  • Fig 22. Food products market, 2018 - 2030 (USD Million)
  • Fig 23. Infant formula market, 2018 - 2030 (USD Million)
  • Fig 24. Sports & functional food market, 2018 - 2030 (USD Million)
  • Fig 25. Pharmaceuticals market, 2018 - 2030 (USD Million)
  • Fig 26. Personal care products market, 2018 - 2030 (USD Million)
  • Fig 27. Others market, 2018 - 2030 (USD Million)
  • Fig 28. Lactoferrin market, by region: Key takeaways
  • Fig 29. Lactoferrin market, by region: Market share, 2024 & 2030
  • Fig 30. North America market, 2018 - 2030 (USD Million)
  • Fig 31. U.S. market, 2018 - 2030 (USD Million)
  • Fig 32. Canada market, 2018 - 2030 (USD Million)
  • Fig 33. Mexico market, 2018 - 2030 (USD Million)
  • Fig 34. Europe market, 2018 - 2030 (USD Million)
  • Fig 35. Germany market, 2018 - 2030 (USD Million)
  • Fig 36. UK market, 2018 - 2030 (USD Million)
  • Fig 37. France market, 2018 - 2030 (USD Million)
  • Fig 38. Italy market, 2018 - 2030 (USD Million)
  • Fig 39. Spain market, 2018 - 2030 (USD Million)
  • Fig 40. Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig 41. China market, 2018 - 2030 (USD Million)
  • Fig 42. India market, 2018 - 2030 (USD Million)
  • Fig 43. Australia & New Zealand market, 2018 - 2030 (USD Million)
  • Fig 44. Japan market, 2018 - 2030 (USD Million)
  • Fig 45. South Korea market, 2018 - 2030 (USD Million)
  • Fig 46. Latin America market, 2018 - 2030 (USD Million)
  • Fig 47. Brazil market, 2018 - 2030 (USD Million)
  • Fig 48. Argentina market, 2018 - 2030 (USD Million)
  • Fig 49. MEA market, 2018 - 2030 (USD Million)
  • Fig 50. UAE market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-871-8

Lactoferrin Market Growth & Trends:

The global lactoferrin market size is estimated to reach USD 486.7 million by 2030, registering to grow at a CAGR of 8.6% from 2025 to 2030 according to a new report by Grand View Research, Inc. Increasing incorporation of lactoferrin in various products ranges including infant food, food supplements, dietetic foods, alcoholic beverages, sports nutrition, and personal care and cosmetics should bolster the lactoferrin market in the forecast timeframe, ascribed to strong health benefits.

Lactoferrin offers stimulating effects on the immune system, prevents cell damage caused by aging, promotes the culture of beneficial bacterial in the intestinal tract, and regulates viruses, bacteria, and fungi along with being regulators to iron metabolism. Lactoferrin is found effective for the treatment of hepatitis C infection by inhibiting replication of the virus at the intracellular level. Hence, the strong applicability of lactoferrin in the nutraceutical, pharmaceutical, and personal care industries is anticipated to drive demand during the forecast period.

Human colostrum has the highest lactoferrin concentration, followed by human milk and then by bovine milk. It is also readily found in human body secretions including the nose, eyes, intestine, and respiratory tract. Lactoferrin can be used as a conjuncture of specific strains of friendly bacteria, together they are proven to boost the immune function of the body, alert the white blood cells of the harmful microbes, and stabilize colonies of gut-friendly bacteria. Commercially, lactoferrin is commonly integrated with probiotics to achieve this.

The Asia Pacific lactoferrin market held the largest revenue share of 30.70% in 2024. The lactoferrin market is projected to witness a strong rise in demand, as the key market players continue adopting strategies to expand their presence in untapped economies of South East Asia. Countries including China, Japan, and Australia have experienced high awareness regarding the health benefits of lactoferrin, which is expected to bolster regional growth over the forecast period.

Lactoferrin Market Report Highlights:

  • The iron absorption segment accounted for the largest share of 39.3% in 2024, primarily due to the increasing prevalence of iron deficiency and related disorders such as anemia, which affects a significant portion of the global population.
  • The infant formula segment dominated the global Lactoferrin market in 2024, driven by the increasing awareness of the health benefits of lactoferrin for infants. Lactoferrin is a crucial component of breast milk, known for its immune-boosting properties and ability to enhance iron absorption.
  • North America accounted for a 23.3% revenue share of the global lactoferrin market in 2024, driven by a combination of rising consumer awareness regarding health and wellness and increasing demand for functional foods.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Insights
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. Lactoferrin Market Variables, Trends & Scope

  • 3.1. Global Lactoferrin Market Outlook
  • 3.2. Industry Value Chain Analysis
  • 3.3. Function Overview
  • 3.4. Average Price Trend Analysis
  • 3.5. Supply-Demand GAP Analysis, 2024
  • 3.6. Regulatory Framework
    • 3.6.1. Policies and Incentive Plans
    • 3.6.2. Standards and Compliances
    • 3.6.3. Regulatory Impact Analysis
  • 3.7. Market Dynamics
    • 3.7.1. Market Driver Analysis
    • 3.7.2. Market Restraint Analysis
    • 3.7.3. Industry Challenges
  • 3.8. Porter's Five Forces Analysis
    • 3.8.1. Supplier Power
    • 3.8.2. Buyer Power
    • 3.8.3. Substitution Threat
    • 3.8.4. Threat from New Entrant
    • 3.8.5. Competitive Rivalry
  • 3.9. PESTEL Analysis
    • 3.9.1. Political Landscape
    • 3.9.2. Economic Landscape
    • 3.9.3. Social Landscape
    • 3.9.4. Technological Landscape
    • 3.9.5. Environmental Landscape
    • 3.9.6. Legal Landscape

Chapter 4. Lactoferrin Market: Function Outlook Estimates & Forecasts

  • 4.1. Lactoferrin Market: Function Movement Analysis, 2024 & 2030
    • 4.1.1. Iron Absorption
      • 4.1.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.1.2. Antiinflammatory
      • 4.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.1.3. Intestinal Flora Protection
      • 4.1.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.1.4. Antibacterial
      • 4.1.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.1.5. Immune Cell Stimulation
      • 4.1.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.1.6. Antioxidant
      • 4.1.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Lactoferrin Market: Application Outlook Estimates & Forecasts

  • 5.1. Lactoferrin Market: Application Movement Analysis, 2024 & 2030
    • 5.1.1. Food Products
      • 5.1.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.1.2. Infant Formula
      • 5.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.1.3. Sports & Functional Food
      • 5.1.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.1.4. Pharmaceuticals
      • 5.1.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.1.5. Personal Care Products
      • 5.1.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.1.6. Others
      • 5.1.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Lactoferrin Market Regional Outlook Estimates & Forecasts

  • 6.1. Regional Snapshot
  • 6.2. Lactoferrin Market: Regional Movement Analysis, 2024 & 2030
  • 6.3. North America
    • 6.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.2. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
    • 6.3.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
    • 6.3.4. U.S.
      • 6.3.4.1. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
      • 6.3.4.2. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
    • 6.3.5. Canada
      • 6.3.5.1. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
      • 6.3.5.2. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
    • 6.3.6. Mexico
      • 6.3.6.1. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
      • 6.3.6.2. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.2. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
    • 6.4.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
    • 6.4.4. Germany
      • 6.4.4.1. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
      • 6.4.4.2. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
    • 6.4.5. UK
      • 6.4.5.1. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
      • 6.4.5.2. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
    • 6.4.6. Italy
      • 6.4.6.1. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
      • 6.4.6.2. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
    • 6.4.7. France
      • 6.4.7.1. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
      • 6.4.7.2. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
    • 6.4.8. Spain
      • 6.4.8.1. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
      • 6.4.8.2. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.2. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
    • 6.5.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
    • 6.5.4. China
      • 6.5.4.1. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
      • 6.5.4.2. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
    • 6.5.5. Japan
      • 6.5.5.1. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
      • 6.5.5.2. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
    • 6.5.6. India
      • 6.5.6.1. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
      • 6.5.6.2. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
      • 6.5.7.2. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
    • 6.5.8. Australia & New Zealand
      • 6.5.8.1. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
      • 6.5.8.2. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.2. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
    • 6.6.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
    • 6.6.4. Brazil
      • 6.6.4.1. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
      • 6.6.4.2. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
    • 6.6.5. Argentina
      • 6.6.5.1. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
      • 6.6.5.2. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
  • 6.7. Middle East & Africa
    • 6.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.2. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
    • 6.7.3. Market estimates and forecast, by application, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Market estimates and forecast, by function, 2018 - 2030 (USD Million)
      • 6.7.4.2. Market estimates and forecast, by application, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Vendor Landscape
    • 7.2.1. Company categorization
    • 7.2.2. List of Key Distributors and Channel Partners
    • 7.2.3. List of Potential Customers/End Users
  • 7.3. Competitive Dynamics
    • 7.3.1. Competitive Benchmarking
    • 7.3.2. Strategy Mapping
    • 7.3.3. Heat Map Analysis
  • 7.4. Company Profiles/Listing
    • 7.4.1. Hilmar Cheese Company
      • 7.4.1.1. Participant's overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Function benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Pharming Group NV
      • 7.4.2.1. Participant's overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Function benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. FrieslandCamina
      • 7.4.3.1. Participant's overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Function benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Synlait Milk Ltd.
      • 7.4.4.1. Participant's overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Function benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Ingredia SA
      • 7.4.5.1. Participant's overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Function benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. MP Biomedicals
      • 7.4.6.1. Participant's overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Function benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Tatura Milk Industries Ltd.
      • 7.4.7.1. Participant's overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Function benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Glanbia plc
      • 7.4.8.1. Participant's overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Function benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. APS BioGroup
      • 7.4.9.1. Participant's overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Function benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. ProHealth
      • 7.4.10.1. Participant's overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Function benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Fonterra Cooperative Group Ltd.
      • 7.4.11.1. Participant's overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Function benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Farbest Brands
      • 7.4.12.1. Participant's overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Function benchmarking
      • 7.4.12.4. Strategic initiatives
    • 7.4.13. InVitria
      • 7.4.13.1. Participant's overview
      • 7.4.13.2. Financial performance
      • 7.4.13.3. Function benchmarking
      • 7.4.13.4 Strategic initiatives
    • 7.4.14. Milei GmbH
      • 7.4.14.1. Participant's overview
      • 7.4.14.2. Financial performance
      • 7.4.14.3. Function benchmarking
      • 7.4.14.4. Strategic initiatives
    • 7.4.15. Ferrin-tech LLC
      • 7.4.15.1. Participant's overview
      • 7.4.15.2. Financial performance
      • 7.4.15.3. Function benchmarking
      • 7.4.15.4. Strategic initiatives